HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
Humana Inc. (HUM) Q2 2025 Earnings Call Transcript
Humana Inc. (NYSE:HUM ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Celeste Marie Mellet - Chief Financial Officer George Renaudin - President of Insurance James A. Rechtin - President, CEO & Director Lisa M.
Top Stock Movers Now: Humana, Hershey, VF Corp., and More
U.S. equities were mixed at midday as the market responded to the U.S. economy growing more than expected in the second quarter while waiting for today's decision by the Federal Reserve on interest rates. The S&P 500 and Nasdaq gained, but the Dow Jones Industrial Average fell.
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop
Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.
Here's What Key Metrics Tell Us About Humana (HUM) Q2 Earnings
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Humana (HUM) Q2 Earnings Lag Estimates
Humana (HUM) came out with quarterly earnings of $6.27 per share, missing the Zacks Consensus Estimate of $6.32 per share. This compares to earnings of $6.96 per share a year ago.
Has Humana turned the corner? Stock jumps as outlook raised, Medicare business improves
Humana's stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.
Insurer Humana raises annual profit forecast, shares climb
Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in premarket trading.
Curious about Humana (HUM) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
HUM's second-quarter earnings are likely to have witnessed strength in insurance premiums and Medicare, partly offset by rising costs and membership declines.
Humana (HUM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana to reduce prior authorization requirements
Humana said on Tuesday it would eliminate about one-third of prior authorizations for outpatient services by January 1, 2026.
